The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock
Oct 04, 2024•over 1 year ago
Contract Type
partnership
ChaskaManufacturingBiotechnologyPharmaceutical
Description
Lifecore Biomedical, Inc. announced the closing of a $24.3 million private placement of its common stock, with the investing group including new and existing shareholders. The company plans to use the proceeds for working capital, operations, and general corporate purposes.
Company Information
Company
Lifecore Biomedical
Location
Chaska, Minnesota, United States
About
Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO) focused on injectable fill/finish capabilities for the pharmaceutical industry. The company has been strategically investing in augmenting its aseptic production capacity and expanding its development pipeline to address the growing demand for injectable fill/finish capabilities.
ChaskaManufacturingBiotechnologyPharmaceutical